simvastatin has been researched along with Diabetic Cardiomyopathies in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Ajmi, HN; Al-Amin, MA; Al-Rasheed, NM; Hasan, IH; Mahmoud, AM; Mohamad, RA | 1 |
| Chen, H; Cui, X; Li, H; Liu, R; Yang, L; Zhao, Q | 1 |
2 other study(ies) available for simvastatin and Diabetic Cardiomyopathies
| Article | Year |
|---|---|
Simvastatin Ameliorates Diabetic Cardiomyopathy by Attenuating Oxidative Stress and Inflammation in Rats.
Topics: Animals; Anticholesteremic Agents; Diabetic Cardiomyopathies; Inflammation; Oxidative Stress; Rats; Simvastatin | 2017 |
Protective Effect and Potential Mechanism of Simvastatin on Myocardial Injury Induced by Diabetes with Hypoglycemia.
Topics: Animals; Calcium; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemia; Male; MicroRNAs; NF-kappa B; Rats; Rats, Sprague-Dawley; Simvastatin | 2018 |